Ultragenyx Pharmaceutical | RARE - Attività Correnti





Attività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Immunic USD 188.76M 165.89M 2026-03
Insmed USD 1.61B 181.04M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Kyowa Hakko Kirin JPY 459.88B 33.47B 2026-03
MacroGenics USD 182.52M 37.42M 2026-03
Moderna USD 5.77B 774M 2026-03
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Xoma USD 110.71M 5.78M 2025-09